InvestorsHub Logo
Followers 27
Posts 4653
Boards Moderated 0
Alias Born 04/30/2005

Re: None

Tuesday, 06/04/2024 1:23:30 PM

Tuesday, June 04, 2024 1:23:30 PM

Post# of 43787
Final protocol for the 212 patient study has or will be submitted to the FDA for approval in the near future. The trial population, since it now will include people who have not yet had but are awaiting surgery, should take less than 6 months. With little downside or side effects from administration of Multikine, it hopefully will be considered a essential standard of care treatment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News